Revance Therapeutics, Inc. recently announced that Angus C. Russell has been appointed as chairman to its board of directors. Russell is a veteran in the global biopharmaceutical industry with over 30 years of experience in commercial execution, operations, and strategic acquisitions. He currently serves on the board of directors at InterMune, Inc. and Questcor Pharmaceuticals, Inc. and from 1999 to 2013, he served as a director at Shire Plc.
